Vimarsana
Biggest News Aggregation in the World

Dual Path Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dual Path Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dual Path Platform Today - Breaking & Trending Today

CDC Laboratory Recommendations for Syphilis Testing, United States, 2024 - Vimarsana News

CDC Laboratory Recommendations for Syphilis Testing, United States, 2024

This report provides new CDC recommendations for tests that can support a diagnosis of syphilis.

Source: cdc.gov
Chembio Diagnostics, Inc. (CEMI) Q3 2022 Earnings Call Transcript - Vimarsana News

Chembio Diagnostics, Inc. (CEMI) Q3 2022 Earnings Call Transcript

Chembio Diagnostics, Inc. (NASDAQ:NASDAQ:CEMI) Q3 2022 Earnings Conference Call November 03, 2022 04:30 PM ET Company Participants Philip Taylor - Investor Relations Rick Eberly - President...

Chembio Diagnostics Reports Third Quarter 2022 Financial Results - Vimarsana News

Chembio Diagnostics Reports Third Quarter 2022 Financial Results

Chembio Diagnostics, Inc. (“Chembio” or the “Company”) (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today

Jenoptik Breaks Ground on Dresden Fab: Week in Brief: 09/09/2022 | Business | Sep 2022 - Vimarsana News

Jenoptik Breaks Ground on Dresden Fab: Week in Brief: 09/09/2022 | Business | Sep 2022

II-VI announced its corporate name change. The company, which finalized its acquisition of Coherent Inc. this summer, is now called Coherent Corp. The

Chembio Diagnostics Receives $3.2M From CDC to Develop Syphilis Test - Vimarsana News

Chembio Diagnostics Receives $3.2M From CDC to Develop Syphilis Test

The rapid assay is intended to simultaneously and separately detect treponemal and nontreponemal IgM and IgG antibodies.

Source: 360dx.com